Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/268,646external-prioritypatent/US4966768A/en
Application filed by American Home Products Corp.filedCriticalAmerican Home Products Corp.
Publication of BG60697B2publicationCriticalpatent/BG60697B2/en
Лекарствената форма намира приложение като аналгетично и противовъзпалително средство. Тя представлява таблетка, съдържаща компонентите 1,2-диетил-1,3,4,9-тетрахидропиранол /3,4/ индол-1-оцетна киселина (етодолак), хидроксипропилметилцелулоза, етилцелулоза и освобождаващ агент, например двуосновен натриев фосфат. Хидроксипропилметилцелулозата съдържа хидроксипропил от 7,0 до 8,6% тегл.The drug form is used as an analgesic and anti-inflammatory agent. It is a tablet comprising 1,2-diethyl-1,3,4,9-tetrahydropyranol (3,4) indole-1-acetic acid (etodolac), hydroxypropylmethylcellulose, ethylcellulose and a release agent, for example dibasic sodium phosphate. Hydroxypropylmethylcellulose contains hydroxypropyl from 7.0 to 8.6% by weight.
BG96617A1988-11-071992-07-15Medicamentous form having continous release based on ethodolacquer
BG60697B2
(en)